Amolyt Pharma is listed on the portfolio pages of Andera Partners (portfolio page) and Eurazeo (portfolio page). Eurazeo lists it as current; Andera Partners lists it as exited. Andera Partners invested in Amolyt Pharma in 2021, per Andera Partners' portfolio page. Eurazeo has owned Amolyt Pharma since 2020, per Eurazeo's portfolio page.
Amolyt Pharma is a Healthcare company. Its owner on record, Andera Partners, is a private equity firm. Andera Partners lists 291 companies in the index, 36 of them in Healthcare. Also backed by Eurazeo.
Andera Partners is a private equity asset management firm that invests in companies and their management to support growth and innovation.
Read the Andera Partners profileEurazeo is a leading French private equity firm and investment group that manages a diversified portfolio of over 600 companies.
Read the Eurazeo profileAmolyt Pharma is listed on the portfolio pages of Andera Partners (portfolio page) and Eurazeo (portfolio page). Eurazeo lists it as current; Andera Partners lists it as exited. Andera Partners invested in Amolyt Pharma in 2021, per Andera Partners' portfolio page. Eurazeo has owned Amolyt Pharma since 2020, per Eurazeo's portfolio page.
Amolyt Pharma is in Healthcare. Classified from the owner's portfolio label.
Andera Partners lists 35 other Healthcare companies in the index, including Adler Ortho, AgoMab, AM Pharma, Artios Pharma and Arvelle.
6 of 290 shown
See the full Andera Partners portfolio.
6 of 265 shown
See the full Eurazeo portfolio.
Browse PE-backed companies.
